Search for: "Paul Regen" Results 61 - 78 of 78
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
12 Jan 2021, 11:28 am by David Jensen
 The matter involves Larry Goldstein, a well-known scientist at UC San Diego, who has received $22 million from the California Institute for Regenerative Medicine (CIRM), the formal name for the stem cell agency. [read post]
12 Jan 2021, 11:28 am by David Jensen
 The matter involves Larry Goldstein, a well-known scientist at UC San Diego, who has received $22 million from the California Institute for Regenerative Medicine (CIRM), the formal name for the stem cell agency. [read post]
25 Oct 2012, 6:47 pm by David Jensen
Paul Laikind, president of ViaCyte, also addressed the board, stressing the importance of CIRM's financial support for his company over past years. [read post]
19 Mar 2012, 1:18 pm by California Stem Cell Report
"The article quoted UC Davis stem cell researcher Paul Knoepfler as favoring another bond measure to keep CIRM afloat, although he said he recognizes the average Californian may disagree. [read post]
9 Dec 2014, 6:43 pm by David Jensen
His proposals for radical changes at the agency are expected to be approved by its governing board on Thursday along with a restructuring aimed at improving speed, efficiency and innovation.It all comes under the rubric of “CIRM 2.0,” a phrase coined by UC Davis stem cell researcher Paul Knoepfler and adopted by Mills after he became president of the California Institute for Regenerative Medicine (CIRM), as the agency is formally known. [read post]
25 Nov 2014, 4:08 pm by David Jensen
Nonetheless, agency has chalked up some indirect scores that are difficult to quantify but deserve ample consideration when evaluating the California Institute for Regenerative Medicine(CIRM), as the agency is formally known. [read post]
6 Jan 2013, 10:37 am by Sai Vinod
Zu's pioneering work in regenerative medicine. [read post]
26 May 2020, 6:31 am by David Jensen
  Infectious disease has not been a particularly major focus of regenerative medicine efforts and many of the approaches we have tried have struggled. [read post]
24 Mar 2019, 3:26 pm
” Andrea Rossi reflects on when Pringles, drunk cart drivers, wine, art, and trade mark law come into contact.PatentsGuestKat Rose Hughes takes a look at the recent application of the Actavis case in the High Court case Regen Lab v Estar [2019] EWHC 63, where the Actavis questions were applied to a numerical value for the first time.InternKat Jonathan Pratt also looks at the application of Actavis in "Formstein defence in the UK? [read post]
1 Jun 2016, 11:08 am by David Jensen
"UC Davis stem cell scientist Paul Knoepfler, writing on his blog The Niche, said the company's demise was "sad. [read post]
7 Dec 2017, 9:30 pm by Sarah Madigan
” The Regulatory Review’s current series, “Valuing Professional Government,” which centers around arguments in Paul R. [read post]
29 Aug 2008, 1:00 pm
” See also California Institute for Regenerative Medicine, Intellectual Property Policy for Non-Profit Organizations, 2-3, (PDF)(defining “Data” and “Biological Materials”).2. [read post]
26 Dec 2021, 9:05 pm by Series of Essays
Strengthening the Stem Cell Industry Through Better Regulation April 6, 2021 | Andrew Ittleman, Fuerst Ittleman David & Joseph, PL FDA should take steps to strengthen the regenerative medicine industry. [read post]
27 Dec 2020, 9:06 pm by Series of Essays
The FDA stem cell lawsuit has potentially precedent-setting implications for the future of stem cell and regenerative medical research. [read post]
22 Sep 2009, 7:00 am
  The WESS flywheel technology captures regenerative braking energy when trains slow or stop and transfer back to same train or another train when it starts or accelerates, reducing energy demand and peak power requirements. [read post]
26 Dec 2018, 9:30 pm by Series of Essays
Invoking a Right to Try in Regenerative Medicine October 24, 2018 | Marissa Fritz The Right to Try Act of 2017 allows anyone who has been diagnosed with a life-threatening disease and has exhausted all treatment options to access a treatment that has completed just the first phase of testing required. [read post]
20 Apr 2020, 12:29 pm by Elliot Setzer
Thornton, Visiting Lecturer in Law at Yale Law School and Senior Fellow at the Paul Tsai Chin Center, and Former Deputy Assistant Secretary of State for East Asian and Pacific Affairs. [read post]